World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
16220
World Ranking
4660
National Ranking
395

Yuting Ma publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yuting Ma sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 125 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yuting Ma D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yuting Ma sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yuting Ma is affiliated with Peking Union Medical College Hospital in China. Their research spans multiple fields, focusing primarily on Medicine and Biochemistry, Genetics and Molecular Biology. They have contributed extensively within subfields such as Molecular Biology, Genetics, Plant Science, Materials Chemistry, and Surgery.

Their work addresses a variety of main topics, including:

  • Genetic Mapping and Diversity in Plants and Animals
  • Genetics and Plant Breeding
  • Cancer-related molecular mechanisms research
  • Covalent Organic Framework Applications
  • Cancer Immunotherapy and Biomarkers
  • Advanced Photocatalysis Techniques
  • Single-cell and spatial transcriptomics

Yuting Ma's recent papers illustrate engagement with diverse research areas and journals. Notable publications include:

  • "Molecular design for electrolyte solvents enabling energy-dense and long-cycling lithium metal batteries" (2020), published in Nature Energy
  • "Spatiotemporal mapping of gene expression landscapes and developmental trajectories during zebrafish embryogenesis" (2022), published in Developmental Cell
  • "Immunomodulatory Effects of Green Tea Polyphenols" (2021), published in Molecules
  • "Can environmental tax promote renewable energy consumption? - An empirical study from the typical countries along the Belt and Road" (2022), published in Energy
  • "Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity" (2020), published in Nature Cell Biology

Frequent coauthors associated with their research collaborations include:

  • Hongwei Zhang
  • Fang Han
  • Xiaodong Sun
  • Wanli Du
  • Pingwei Liu

Their scholarly output appears regularly in several publication venues. These include:

  • Research Square (Research Square)
  • International Journal of Molecular Sciences
  • Frontiers in Plant Science
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric

  • Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.

    Mickaël Michaud;Mickaël Michaud;Mickaël Michaud;Isabelle Martins;Isabelle Martins;Isabelle Martins;Abdul Qader Sukkurwala;Abdul Qader Sukkurwala;Abdul Qader Sukkurwala;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies

    Laurence Zitvogel;Yuting Ma;Didier Raoult;Guido Kroemer

  • Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

    Yuting Ma;Yuting Ma;Yuting Ma;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Stephen R. Mattarollo;Takahiro Yamazaki;Takahiro Yamazaki;Takahiro Yamazaki

  • Molecular mechanisms of ATP secretion during immunogenic cell death

    Martins I;Wang Y;Wang Y;Wang Y;Michaud M;Michaud M;Michaud M;Ma Y;Ma Y;Ma Y

  • Autophagy and cellular immune responses

    Yuting Ma;Yuting Ma;Yuting Ma;Lorenzo Galluzzi;Lorenzo Galluzzi;Laurence Zitvogel;Laurence Zitvogel;Guido Kroemer

  • Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade.

    Fangyuan Zhou;Fangyuan Zhou;Bing Feng;Haijun Yu;Dangge Wang

  • A dual role for autophagy in a murine model of lung cancer

    Shuan Rao;Luigi Tortola;Thomas Perlot;Gerald Wirnsberger

  • Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

    Yuting Ma;Laetitia Aymeric;Clara Locher;Stephen R Mattarollo

  • Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death

    Laurie Menger;Erika Vacchelli;Erika Vacchelli;Erika Vacchelli;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Isabelle Martins;Isabelle Martins;Isabelle Martins

  • Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

    Erika Vacchelli;Yuting Ma;Elisa E. Baracco;Antonella Sistigu

  • Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.

    Stephen R Mattarollo;Sherene Loi;Helene Duret;Yuting Ma

  • Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity

    Heng Yang;Lin Xia;Jian Chen;Shuqing Zhang

  • Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

    Yuting Ma;Yuting Ma;Laetitia Aymeric;Laetitia Aymeric;Clara Locher;Clara Locher;Stephen R. Mattarollo

  • Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

    Laura Senovilla;Erika Vacchelli;Jerome Galon;Sandy Adjemian

  • Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Peng Liu;Liwei Zhao;Jonathan Pol;Sarah Levesque

  • Chemotherapy and radiotherapy: cryptic anticancer vaccines

    Yuting Ma;Oliver Kepp;François Ghiringhelli;Lionel Apetoh;Lionel Apetoh;Lionel Apetoh

  • Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

    Heng Yang;Yuting Ma;Guo Chen;Heng Zhou

  • Harnessing γδ T cells in anticancer immunotherapy

    Dalil Hannani;Yuting Ma;Yuting Ma;Yuting Ma;Takahiro Yamazaki;Takahiro Yamazaki;Takahiro Yamazaki;Julie Déchanet-Merville

Frequent Co-Authors

Guido Kroemer
Guido Kroemer Université Paris Cité
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Erika Vacchelli
Erika Vacchelli Université Paris Cité
Isabelle Martins
Isabelle Martins Inserm : Institut national de la santé et de la recherche médicale
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Takahiro Yamazaki
Takahiro Yamazaki Cornell University
Lionel Apetoh
Lionel Apetoh Indiana University
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Antoine Tesniere
Antoine Tesniere Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various related healthcare careers, many of which you can pursue through flexible online degree programs. For nurses looking to expand their scope, transitioning from a Family Nurse Practitioner (FNP) to an acute care setting can be achieved through specialized training. Explore how to make this career move with fnp to acute care np pathways that focus on advanced clinical skills.

If you’re seeking a quicker route into nursing practice, consider an accelerated nurse practitioner program. These online programs are designed to fast-track your education, enabling you to enter high-demand specialties swiftly. Similarly, for individuals without a nursing background, there are accessible options like online rn programs for non nurses that provide comprehensive foundational training in nursing theory and practice.

Additionally, exploring accelerated bsn programs for non nurses offers another viable path to enter the field. These programs emphasize efficiency and accessibility, enabling career changers to gain a Bachelor of Science in Nursing (BSN) in a shorter timeframe. Together, these options highlight the diverse and flexible educational routes available for advancing your career within immunology-related healthcare roles.

Best Scientists Citing Yuting Ma

Trending Scientists

Recently Published Articles